Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

NCT07254754 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

DIFFUSE LARGE B-CELL LYMPHOMA

Interventions

DRUG: Axicabtagene Ciloleucel

Sponsor

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Collaborators

[object Object]
[object Object]